Pure red cell aplasia caused by pegylated interferon-α-2a plus ribavirin in the treatment of chronic hepatitis C

World Journal of Gastroenterology

Volumn 17, Issue 16, 2011, Pages 2155-2158

  Chang, Cheng Shyong ^a   Yan, Sheng Lei ^b,c   Lin, Hsuan Yu ^a   Yu, Fu Lien ^a,d   Tsai, Chien Yu ^a  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHANG BING SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^c DA YEH UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chronic hepatitis C; Pegylated interferon 2a; Pure red cell aplasia; Ribavirin

Indexed keywords

CYANOCOBALAMIN; METHYLPREDNISOLONE; PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

AGED; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; CYANOCOBALAMIN DEFICIENCY; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PURE RED CELL ANEMIA; RETICULOCYTE COUNT; VIRUS LOAD;

EID: 79955933586     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i16.2155     Document Type: Article

References (23)

1. Fisch P, Handgretinger R, Schaefer HE. Pure red cell apla-sia. Br J Haematol 2000; 111: 1010-1022
2. Schecter JM, Mears JG, Alobeid B, Gaglio PJ. Anti-erythro-poietin antibody-mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus. Liver Transpl 2007; 13: 1589-1592
3. Tanaka N, Ishida F, Tanaka E. Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C. N Engl J Med 2004; 350: 1264-1265
4. Tomita N, Motomura S, Ishigatsubo Y. Interferon-alpha-induced pure red cell aplasia following chronic myelogenous leukemia. Anticancer Drugs 2001; 12: 7-8
5. Hirri HM, Green PJ. Pure red cell aplasia in a patient with chronic granulocytic leukaemia treated with interferon-alpha. Clin Lab Haematol 2000; 22: 53-54
6. Miura Y, Kami M, Yotsuya R, Toda N, Komatsu T. Pure red-cell aplasia associated with pegylated interferon-alpha-2b plus ribavirin. Am J Hematol 2008; 83: 758-759
7. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gonçales FL, Häussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J. Peginterfer-on alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982
8. Peck-Radosavljevic M, Wichlas M, Homoncik-Kraml M, Kreil A, Hofer H, Jessner W, Gangl A, Ferenci P. Rapid suppression of hematopoiesis by standard or pegylated interferon-alpha. Gastroenterology 2002; 123: 141-151
9. De Franceschi L, Fattovich G, Turrini F, Ayi K, Brugnara C, Manzato F, Noventa F, Stanzial AM, Solero P, Corrocher R. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage. Hepatology 2000; 31: 997-1004
10. Bodenheimer HC, Lindsay KL, Davis GL, Lewis JH, Thung SN, Seeff LB. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial. Hepatology 1997; 26: 473-477
11. Tomida S, Matsuzaki Y, Nishi M, Ikegami T, Chiba T, Abei M, Tanaka N, Osuga T, Sato Y, Abe T. Severe acute hepatitis A associated with acute pure red cell aplasia. J Gastroenterol 1996; 31: 612-617
12. Handa SI, Schofield KP, Sivakumaran M, Short M, Pumphrey RS. Pure red cell aplasiaassociated with malignant thymoma, myasthenia gravis, polyclonal large granular lymphocytosis and clonal thymic T cell expansion. J Clin Pathol 1994; 47: 676-679
13. Linardaki GD, Boki KA, Fertakis A, Tzioufas AG. Pure red cell aplasia as presentation of systemic lupus erythematosus: antibodies to erythropoietin. Scand J Rheumatol 1999; 28: 189-191
14. Arcasoy MO, Rockey DC, Heneghan MA. Pure red cell aplasia following pegylated interferon alpha treatment. Am J Med 2004; 117: 619-620
15. Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 2008; 142: 505-514
16. Clark DA, Dessypris EN, Krantz SB. Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 1984; 63: 277-286
17. Al-Awami Y, Sears DA, Carrum G, Udden MM, Alter BP, Conlon CL. Pure red cell aplasia associated with hepatitis C infection. Am J Med Sci 1997; 314: 113-117
18. Mamiya S, Itoh T, Miura AB. Acquired pure red cell aplasia in Japan. Eur J Haematol 1997; 59: 199-205
19. Lahner E, Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol 2009; 15: 5121-5128
20. Dan K, Ito T, Nomura T. Pure red cell aplasia following pernicious anemia. Am J Hematol 1990; 33: 148-150
21. Robins-Browne RM, Green R, Katz J, Becker D. Thymoma, pure red cell aplasia, pernicious anaemia and candidiasis: a defect in immunohomeostasis. Br J Haematol 1977; 36: 5-13
22. Goldstein C, Pechet L. Chronic Erythrocytic Hypoplasia Following Pernicious Anemia. Blood 1965; 25: 31-36
23. Schattner A. The possible involvement of interferons in acquired pure red cell aplasia. Am J Hematol 1988; 27: 72-73